Location History:
- South Australia, AU (2018)
- Firle, AU (2001 - 2022)
Company Filing History:
6 out of 64 
5 out of 323 
5 out of 11 Years Active: 2001-2025
Title: **John Charles Mulley: Innovator in Genetic Research and Disorder Diagnosis**
Introduction
John Charles Mulley is a notable inventor based in Firle, AU, recognized for his extensive contributions to the field of genetic research. With 13 patents to his name, Mulley's work primarily focuses on the diagnosis and prognosis of seizure and movement disorders, showcasing his commitment to advancing medical science.
Latest Patents
Among his most recent inventions is a groundbreaking patent titled "Gene and mutations thereof associated with seizure and movement disorders." This invention relates to the proline rich transmembrane protein 2 (PRRT2) gene, highlighting the identification of mutations and variations that can lead to various disorders. The patent outlines methods for diagnosing and prognosing these conditions by detecting alterations in the PRRT2 gene. Such discoveries also enable the identification of individuals at risk of passing on these disorders to their offspring. Additionally, Mulley has patented diagnostic and therapeutic methods for EFMR (epilepsy and mental retardation limited to females), offering innovative kits and methods for diagnosing conditions related to protocadherin 19 (PCDH19) protein deficiencies. This includes screening and therapeutic strategies aimed at managing PCDH19-related illnesses.
Career Highlights
Throughout his career, John Charles Mulley has collaborated with reputable organizations, particularly Bionomics Inc. and The University of Melbourne. His work at these institutions has been instrumental in pushing the boundaries of genetic research and disease understanding.
Collaborations
Mulley's collaborations with prominent figures in the field, including Samuel Frank Berkovic and Leanne Michelle Dibbens, have further enriched his research endeavors. These partnerships have allowed for a greater exchange of knowledge and fostered innovation within the science community.
Conclusion
John Charles Mulley stands out as a significant contributor to the field of genetics, particularly in relation to seizures and movement disorders. His 13 patents reflect a dedication to improving diagnostic methods and therapeutic approaches, ultimately advancing the understanding and treatment of genetic conditions. As he continues his research, Mulley's innovations are likely to impact many lives positively.